← All organizations
Highest phase reached
Phase 3
First clinical trial
Jan 22, 2020Last known activity
Jun 1, 2026
Timeline
No events for the selected filters.
Drugs by trial phase (65 distinct, 26 trials)
Phase 3 (34 own, 0 via acquisition)
Phase 2 (29 own, 0 via acquisition)
Other trials (2 own, 0 via acquisition)
Recent trials (43)
- NCT07061964OfficialPhase 2Jun 1, 2026
- NCT07220187Lead sponsorPhase 3May 2, 2026
- NCT07220187OfficialPhase 3May 2, 2026
- NCT06998940OfficialPhase 3Jan 6, 2026
- NCT06998940Lead sponsorPhase 3Jan 6, 2026
- NCT07062354Lead sponsorPhase 2Dec 31, 2025
- NCT07062354OfficialPhase 2Dec 31, 2025
- NCT07042295OfficialPhase 2Dec 22, 2025
- NCT06769126Lead sponsorPhase 2Dec 1, 2025
- NCT06769126OfficialPhase 2Dec 1, 2025
- NCT06616584Lead sponsorPhase 2/Phase 3Jul 11, 2025
- NCT06616584OfficialPhase 2/Phase 3Jul 11, 2025
- NCT06807437Lead sponsorPhase 3Jun 28, 2025
- NCT06807437OfficialPhase 3Jun 28, 2025
- NCT06498635OfficialPhase 3Mar 14, 2025
Details
- Last known activity
- Jun 1, 2026